Oseltamivir Phosphate with at Least a 10-year Shelf Life
Award Notice Posted
- Solicitation number
- 75A50325F80003
- Agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Awarded
- to Genentech Usa, Inc.
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 36F79723D0219-75A50325F80003 Federal contract award
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- South San Francisco, California 94080, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response has awarded a firm-fixed-price delivery order (Contract 75A50325F80003) to Genentech USA, Inc. for $396,999,400 to supply oseltamivir phosphate (Tamiflu) 30mg and 75mg capsules with a minimum 10-year shelf life. The contract, awarded on January 31, 2025, has a 24-month period of performance and was justified under a Limited Source Justification, as Genentech is the only source capable of providing the specialized pharmaceutical product for the Strategic National Stockpile. The antiviral medication, which inhibits viral replication and is used to treat acute Influenza A and B, will replace existing expiring stockpiles and ensure long-term availability of critical medical supplies for emergency preparedness.
Notice text
Delivery order 75A50325F80003 was awarded under the authority of a Limited Source Justification pursuant to FAR 8.405-6(a)(1)(i)(B), only one source is capable of providing the supplies required at the level or quality required because the supplies or services are unique or highly specialized for the supply of oseltamivir phosphate with at least a 10-year shelf life.
The NAICS code for this procurement is 325412, Pharmaceutical and Preparation Manufacturing. Period of performance – from date of award for 24 months thereafter.
The Administration for Strategic Preparedness and Response, Center for the Strategic National Stockpile (SNS) awarded a firm fixed-price delivery order to Genentech USA, Inc., located at 1 DNA Way, South San Francisco, CA 94080-4918. This delivery order was awarded to replace expiring Tamiflu (oseltamivir phosphate) 30mg and 75mg capsules with long shelf-life oseltamivir phosphate 30mg and 75mg capsules with at least a 10-year shelf-life. Replacement ensures that the SNS maintains its stockpile of Influenza antivirals that have long-term stability and potency, and that remain deployable and available for an emergency without any additional procurement or government-funded drug stability studies. Oseltamivir phosphate is an antiviral medication primarily used to treat acute Influenza A and B in patients experiencing symptoms for less than 48 hours. Oseltamivir phosphate works by inhibiting a key enzyme necessary for viral replication, reducing the severity and duration of flu symptoms, facilitating faster recovery, and offering preventative benefits when exposure to the virus occurs.
Awarded contract 36F79723D0219 to GENENTECH USA, INC for 396999400.00 on 2025-01-31.
Files
| File | Type | Posted |
|---|---|---|
| LSJ_FY25 Oseltamivir Phosphate_Redacted Version.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity